Clinical Biomarkers in Alpha-mannosidosis

Alpha-mannosidosis

Expanded Access to Velmanase Alfa Lamazym Aftercare Study Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients Evaluation of Long-term Efficacy of Treatment With Lamazym Clinical Biomarkers in Alpha-mannosidosis A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis Dose Finding Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis Safety Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis Biomarker for Mannosidosis Disease (BioMannosidosis)